Home » FDA to Study Impact of Price Incentives in DTC Ads
FDA to Study Impact of Price Incentives in DTC Ads
The FDA plans to study whether coupons offering purchase incentives, such as money-back guarantees, in direct to consumer (DTC) print ads affect consumers’ perceptions of the risks and benefits of a product. Price incentives may mislead consumers who may use the incentives as signals about product quality, the FDA says in a notice published in the Federal Register.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May